According to the World Health Organization (WHO), in 2019, approximately 1.74 billion people required treatment for neglected tropical diseases, including soil-transmitted helminths . Common species that affect people are threadworms (Strongyloides stercoralis), hookworms (Ancylostoma duodenale and Necator americanus), and roundworms (Ascaris lumbricoides). These worms feed on iron and protein from the host tissues, causing infections with symptoms ranging from abdominal pain 2 to anemia , and physical and cognitive growth impairments, affecting children worse than adults . Some parasites also cause loss of appetite, diarrhea, or dysentery, reducing nutritional intake and starvation. Soil-transmitted helminth infections are a significant problem for developing nations in tropical and subtropical areas. The World Health Assembly endorsed a resolution (WHA54. 19) urging affected countries to control morbidity by periodically treating at-risk people, particularly preschool and school-age children, pregnant women, and high-risk workers (tea-pickers, miners, farmers, etc.). The prevalence of helminthic infections necessitates the development of affordable and efficient medication that can be distributed across broad geographic regions. These medicines are also provided as part of schoolbased deworming initiatives, usually given to primary school students once a year. Therefore, it is beneficial to formulate the active pharmaceutical ingredients as palatable drugs, such as sweet and sour chewable tablets.